Edward B Iii Smith Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Edward Smith HTBX stock SEC Form 4 insiders trading

Edward has made over 1 trades of the Heat Biologics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Edward sold 103,304 units of HTBX stock worth $106,403 on 12 November 2020.

The largest trade Edward's ever made was selling 103,304 units of Heat Biologics Inc stock on 12 November 2020 worth over $106,403. On average, Edward trades about 9,391 units every 0 days since 2014.

You can see the complete history of Edward Smith stock trades at the bottom of the page.

What's Edward Smith's mailing address?

Edward's mailing address filed with the SEC is C/O HEAT BIOLOGICS, INC., 627 DAVIS DRIVE, MORRISVILLE, NC, 27560.

Insiders trading at Heat Biologics Inc

Over the last 11 years, insiders at Heat Biologics Inc have traded over $311,853 worth of Heat Biologics Inc stock and bought 1,805,692 units worth $1,373,576 . The most active insiders traders include Louis C Bock, Michael Kharitonov, and John K A Prendergast. On average, Heat Biologics Inc executives and independent directors trade stock every 319 days with the average trade being worth of $582,988. The most recent stock trade was executed by John K A Prendergast on 14 May 2021, trading 35,000 units of HTBX stock currently worth $205,450.

What does Heat Biologics Inc do?

Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, and a COVID-19 vaccine program in preclinical development. In addition, Heat Biologics is also developing a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.

Complete history of Edward Smith stock trades at Heat Biologics Inc

Heat Biologics Inc executives and stock owners

Heat Biologics Inc executives and other stock owners filed with the SEC include:

• Jeffrey Alan Wolf J.D.,
  Founder, Chairman, CEO & Pres
• Jeffrey Alan Wolf,
  Founder, Chairman, CEO & Pres
• William L. Ostrander,
  CFO & Sec.
• Dr. Paul W. Tebbey M.B.A., Ph.D.,
  Sr. VP of Product Devel. & Portfolio Strategy
• Dr. Anthony M. Manning Ph.D.,
  Chief Scientific Advisor
• Colonel George E. Peoples Jr., F.A.C.S., FACS, M.D.,
  Chief Medical Advisor
• Dr. Anthony M. Manning,
  Chief Scientific Advisor
• Colonel George E. Peoples Jr., F.A.C.S., M.D., FACS,
  Chief Medical Advisor
• Dr. Justin Stebbing M.D., M.A., FRCP, FRCPath, Ph.D.,
  Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
• John J Monahan,
  Director
• Edward B Iii Smith,
  Director
• Michael Kharitonov,
  Director
• Jeffrey Alan Wolf,
  Chief Executive Officer
• John K A Prendergast,
  Director
• Ann A Rosar,
  VP of Finance and Controller
• Robert James Jakobs,
  VP Finance/Controller/Secty
• Anil K. Goyal,
  VP of Business Development
• Louis C Bock,
  Director
• Paul Belsky,
  Director
• Timothy J Creech,
  Chief Financial Officer
• Melissa Price,
  VP Clinical/Regulatory Affairs
• Taylor Schreiber,
  Vice President of Research
• Jeffrey Alan Orion Holdings...,
  Chief Executive Officer
• Capital Management, Llc Bri...,
  
• Matthew E Czajkowski,
  Chief Financial Officer
• Jeff Tobin Hutchins,
  CSO and COO
• William L. Ostrander,
  CFO/Corp Secy